Findlay Park Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-369,351
| Closed | -$136M | – | 59 |
|
|
2024
Q4 | $136M | Buy |
369,351
+6,500
| +2% | +$2.4M | 1.35% | 38 |
|
|
2024
Q3 | $189M | Buy |
362,851
+70,700
| +24% | +$36.8M | 1.78% | 26 |
|
|
2024
Q2 | $158M | Sell |
292,151
-2,200
| -0.7% | -$1.19M | 1.49% | 31 |
|
|
2024
Q1 | $153M | Sell |
294,351
-5,000
| -2% | -$2.59M | 1.4% | 30 |
|
|
2023
Q4 | $141M | Buy |
299,351
+78,841
| +36% | +$37.2M | 1.39% | 33 |
|
|
2023
Q3 | $96M | Buy |
220,510
+55,636
| +34% | +$24.2M | 1.03% | 45 |
|
|
2023
Q2 | $73.3M | Buy |
+164,874
| New | +$73.3M | 0.75% | 47 |
|
|
2020
Q3 | – | Sell |
-112,500
| Closed | -$29.6M | – | 47 |
|
|
2020
Q2 | $29.6M | Sell |
112,500
-137,500
| -55% | -$36.2M | 0.23% | 48 |
|
|
2020
Q1 | $56.8M | Buy |
250,000
+175,000
| +233% | +$39.7M | 0.55% | 43 |
|
|
2019
Q4 | $22.7M | Buy |
+75,000
| New | +$22.7M | 0.18% | 51 |
|